Truth Initiative
An article about the Truth Initiative, a nonprofit organization dedicated to tobacco control and public health.
The Truth Initiative is a nonprofit organization in the United States dedicated to achieving a culture where all youth and young adults reject tobacco. It is known for its public health campaigns, research, and community engagement efforts aimed at reducing tobacco use and its harmful effects.
History[edit]
The Truth Initiative was established in 1999 as the American Legacy Foundation as part of the Master Settlement Agreement between the tobacco industry and 46 U.S. states. The organization was created to address the public health crisis caused by tobacco use and to prevent youth smoking.
Mission and Goals[edit]
The mission of the Truth Initiative is to inspire tobacco-free lives and to create a world where tobacco use and nicotine addiction are things of the past. The organization focuses on:
- Preventing youth smoking and vaping
- Helping current tobacco users quit
- Conducting research on tobacco use and its effects
- Advocating for policies that reduce tobacco use
Programs and Campaigns[edit]
The Truth Initiative is best known for its "truth" campaign, which uses innovative and engaging media to educate young people about the dangers of tobacco use. The campaign employs social media, television, and digital platforms to reach its audience.
Research and Policy[edit]
The organization conducts extensive research on tobacco use, addiction, and cessation. It publishes reports and studies that inform public health policies and initiatives. The Truth Initiative also advocates for policies that reduce tobacco use, such as increasing tobacco taxes and implementing smoke-free laws.
Community Engagement[edit]
The Truth Initiative works with communities across the United States to support local efforts to reduce tobacco use. It provides resources and training to help communities implement effective tobacco control strategies.
Impact[edit]
Since its inception, the Truth Initiative has played a significant role in reducing youth smoking rates in the United States. Its campaigns and programs have contributed to a decline in tobacco use among young people and have raised awareness about the health risks associated with smoking and vaping.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian